首页> 外文期刊>Expert opinion on pharmacotherapy >Colostrinin: a naturally occurring compound derived from mammalian colostrum with efficacy in treatment of neurodegenerative diseases, including Alzheimer's.
【24h】

Colostrinin: a naturally occurring compound derived from mammalian colostrum with efficacy in treatment of neurodegenerative diseases, including Alzheimer's.

机译:初乳素:天然存在于哺乳动物初乳中的化合物,具有治疗神经退行性疾病(包括阿尔茨海默氏病)的功效。

获取原文
获取原文并翻译 | 示例
           

摘要

Neurodegenerative illnesses such as Alzheimer's disease and their debilitating effects pose a major problem as their incidence increases. Although clinical management of neurodegenerative diseases usually involves symptomatic treatment, Colostrinin() (CLN), which has efficacy in counteracting neural degradation and in stimulating neural growth, might prove to be a more effective means to deal with the causes of Alzheimer's and other neurodegenerative diseases. Evidence for the clinical efficacy of CLN is discussed and recent data examined showing the remarkable ability of CLN to reduce oxidative stress, prevent beta-amyloid aggregation and prolong the lifespan in a laboratory model of premature ageing. An increasingly important application for CLN has been as a nutraceutical product for use in the early stages of cognitive decline in humans, with licensed use in North America and Australia, and now in Europe. It might also be of considerable utility as a veterinary nutraceutical for companion animals.
机译:随着其发病率的增加,神经退行性疾病,例如阿尔茨海默氏病及其使人衰弱的作用成为一个主要问题。尽管神经退行性疾病的临床管理通常涉及对症治疗,但Colostrinin()(CLN)具有对抗神经退化和刺激神经生长的功效,可能被证明是解决阿尔茨海默氏病和其他神经退行性疾病病因的更有效手段。 。讨论了CLN临床疗效的证据,并检查了最近的数据,这些数据显示CLN在过早老化的实验室模型中具有降低氧化应激,防止β-淀粉样蛋白聚集和延长寿命的显着能力。 CLN的日益重要的应用已成为一种营养产品,用于人类认知能力减退的早期阶段,并在北美和澳大利亚以及现在在欧洲获得许可使用。作为伴侣动物的兽医营养保健品,它也可能具有相当大的用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号